Organic Process Research & Development 2001, 5, 167−175
Optimization and Scale-Up of a Novel Process for 2-Aminoindan Hydrochloride
Production
Didier Roche, David Sans, Michael J. Girgis,* Kapa Prasad,* Oljan Repic, and Thomas J. Blacklock
Process R & D, Chemical and Analytical DeVelopment, NoVartis Institute for Biomedical Research,
59 Route 10, East HanoVer, New Jersey 07936, U.S.A.
Scheme 1. Literature preparations of 2-aminoindan HCl
salt using either 1- or 2-indanone
Abstract:
The need for an economical process for producing 2-aminoin-
dan hydrochloride, a key starting material in manufacturing
novel bioactive molecules, motivated development of a novel
synthetic route using an inexpensive reactant, ninhydrin. The
synthesis, involving oximation of ninhydrin followed by catalytic
reduction of the resulting oxime intermediate to give 2-ami-
noindan, was demonstrated successfully, and a product puri-
fication scheme was developed to isolate 2-aminoindan as the
hydrochloride salt form. Subsequent process development
optimized the reduction step by identifying regimes of fast and
slow reaction (corresponding to reduction of oxime and diketone
functions, respectively), and tailoring reaction conditions to use
mild conditions during the fast exothermic regime to ensure
process safety followed by more severe conditions for the slower
reaction. The process was successfully scaled up 100-fold in a
pilot plant, with excellent yield and product quality agreement
between laboratory and pilot plant.
Scheme 2. Proposed 2-aminoindan hydrochloride
preparation from ninhydrin
of preparing 2-aminoindan hydrochloride from ninhydrin, (b)
develop and optimize a process for scale-up in a pilot plant
and commercial facility, and (c) demonstrate the process on
a large scale and thus prove the synthetic utility of Scheme
2 for bulk-scale 2-aminoindan hydrochloride production.
Introduction
The difficulty in rapidly obtaining bulk amounts of
2-aminoindan hydrochloride, a key starting material in
producing bioactive molecules, prompted an in-house evalu-
ation and development of synthetic routes for its economical
large-scale production. Literature preparations of the 2-ami-
noindan involve oximation of either 1-indanone1 or 2-in-
danone,2 followed by reduction of the oxime and ketone
functions (Scheme 1). However, the relatively high costs of
both 1-indanone and 2-indanone preclude their large-scale
use as starting materials.
The structural similarity of ninhydrin to 1- or 2-indanone,
its availability in bulk amounts (owing to its use as an
analytical reagent for detecting primary amines3), and its low
cost relative to that of 1-indanone and 2-indanone prompted
evaluation of an analogous oximation/reduction sequence
(Scheme 2) using ninhydrin. Preparation of the oxime by
reaction of ninhydrin with hydroxylamine hydrochloride in
ethanol has been reported previously.4 The objectives of this
work were thus to (a) demonstrate the synthetic feasibility
Experimental Section
Apparatus and Materials. Process development experi-
ments were performed using a Mettler-Toledo RC1 reaction
calorimeter equipped with a 1-L jacketed glass vessel rated
for 10-bar operation, a Hastelloy C pitched-blade agitator, a
hydrogen gas reservoir, a pressure regulator for setting the
reactor pressure, and valves for venting and purging (Figure
1). Calorimeter operating principles are discussed elsewhere.5
Sources and purities of materials used are given in Table
1. All materials were used as received. Although we used
hydroxylamine in the salt form, the free base could undergo
a runaway reaction leading to an explosion.6 Two dry 10%
Pd/C catalysts and two wet 10% Pd/C catalysts were
investigated.
Reaction Monitoring and Product Analysis. For reac-
tion monitoring, samples were analyzed by HPLC using a
Hewlett-Packard Series 1000 HPLC equipped with a UV
detector. Method details are given in Table 2.
In process development experiments, reaction calorimetry
was also used to monitor reaction progress. During the
(1) Paul, H. J. Prakt. Chem. 1965, 28, 297; Nichols, D. E. J. Med. Chem. 1974,
17, 161-165; Cannon, J. G. J. Med. Chem. 1982, 25, 1442-1446; Johnson,
M. P. J. Med. Chem. 1991, 34, 1662-1668.
(2) Levin, J. Org. Chem. 1944, 380-386; Rosen, J. Org. Chem. 1963, 28,
2797-2801; Paleo, M. Tetrahedron Lett. 1994, 11, 3627-3638.
(3) The Merck Index, 12th ed.; Budavari, S., Ed.; Merck & Co.: Whitehouse
Station, NJ, 1996; p. 1126.
(5) Girgis, M. J.; Kiss, K.; Ziltener, C. A.; Prashad, M.; Har, D.; Yoskowitz,
R. S.; Basso, B.; Repic, O.; Blacklock, T. J.; Landau, R. N. Org. Process
Res. DeV. 1997, 1, 339-349.
(6) Herman, S.; Zhenglong, X.; Sundareswaran, p. C.; Wang, Z. 218th ACS
National Meeting, Book of Abstracts; American Chemical Society: Wash-
ington, DC, Aug. 22-26, 1999.
(4) Paria, P. K., et al. J. Indian Chem. Soc. 1990, 67, 532.
10.1021/op000222h CCC: $20.00 © 2001 American Chemical Society and The Royal Society of Chemistry
Published on Web 02/02/2001
Vol. 5, No. 2, 2001 / Organic Process Research & Development
•
167